Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Traditional high-throughput drug screening in oncology routinely relies on two-dimensional (2D) cell models, which inadequately recapitulate the physiologic context of cancer. Three-dimensional (3D) cell models are thought to better mimic the complexity of in vivo tumors. Numerous methods to culture 3D organoids have been described, but most are nonhomogeneous and expensive, and hence impractical for high-throughput screening (HTS) purposes. Here we describe an HTS-compatible method that enables the consistent production of organoids in standard flat-bottom 384- and 1536-well plates by combining the use of a cell-repellent surface with a bioprinting technology incorporating magnetic force. We validated this homogeneous process by evaluating the effects of well-characterized anticancer agents against four patient-derived pancreatic cancer KRAS mutant-associated primary cells, including cancer-associated fibroblasts. This technology was tested for its compatibility with HTS automation by completing a cytotoxicity pilot screen of ~3300 approved drugs. To highlight the benefits of the 3D format, we performed this pilot screen in parallel in both the 2D and 3D assays. These data indicate that this technique can be readily applied to support large-scale drug screening relying on clinically relevant, ex vivo 3D tumor models directly harvested from patients, an important milestone toward personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Zhang, J.-H., Chung, T. D. Y., & Oldenburg, K. R. (1999) · SLAS Discovery · doi:10.1177/108705719900400206 · Cited by 6,847 · cited 2×
“5.(5) Compound activity was normalized on a per-plate basis using the following equation:(23)”
MethodModeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · cited 1×
“Organoids, on the other hand, are defined as 3D cellular clusters typically derived specifically from primary tissue, embryonic stem cells, or induced pluripotent stem cells.(2,3,12) Organoid cultures traditionally rely on artificial extracellular matrices (ECMs) such as Matrigel to facilitate their self-organization…”
BackgroundOrganoid models of human and mouse ductal pancreatic cancer
Boj, S. F., Hwang, C.-I., Baker, L. A., Chio, I. I. C., Engle, D. D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M. S., et al. (2015) · Cell · doi:10.1016/j.cell.2014.12.021 · Cited by 2,150 · cited 3×
“Organoid cultures traditionally rely on artificial extracellular matrices (ECMs) such as Matrigel to facilitate their self-organization into structures that closely mimic the features of in vivo tissue.(10,13) Due to the difficulty in early diagnosis and lack of effective treatment, pancreatic cancer remains one of th…”
BackgroundMethodSelf-citationPancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058 · cited 1×
“Pancreatic cancer is recognized as a heterogeneous cancer with genotypic and phenotypic diversity observed not only between patients but also within a tumor.(7,11) In this study, we employed the bioprinting technique using n3D technology and grew spheroids in flat-bottom, cell-repellent plates in the absence of exogen…”
BackgroundSelf-citationSpheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742 · cited 1×
“In addition, the human colorectal adenocarcinoma cell line HT-29 was used as a control cell line due to its inclination to form spheroids.(26) Some cells are indeed more inclined to form spheroids than others (Fig.”
MethodThe Pancreas Cancer Microenvironment
Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3114 · Cited by 1,316
Self-citationRecent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264 · cited 1×
“The different 3D-forming ability among the tested panel of cells is likely due to the different expression levels of adhesion molecules, such as β1-integrin and E-cadherin, and the interaction of β1-integrin with ECM proteins, which are required during spheroid formation, similarly to what has been demonstrated in hep…”
BackgroundZanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A. (2016) · Scientific Reports · doi:10.1038/srep19103 · Cited by 1,144 · cited 1×
“Traditional monolayer cancer models exhibit an unrestrained proliferation phenotype, which has proven limited value in predicting clinical response to novel agents.(1) 3D ex vivo tumor models are able to better recapitulate the features of in vivo cancer, such as cell–cell interactions, cell– matrix interactions, hypo…”
BackgroundProgression model for pancreatic cancer.
Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 1,102
3D tumor spheroids: an overview on the tools and techniques used for their analysis
Costa, E. C., Moreira, A. F., de Melo-Diogo, D., Gaspar, V. M., Carvalho, M. P., & Correia, I. J. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.11.002 · Cited by 929
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Self-citationAlcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., et al. (2017) · Nature · doi:10.1038/nature25016 · Cited by 807
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674 · cited 1×
“Disulfiram, an aldehyde dehydrogenase inhibitor, has also been shown to inhibit other actvities, such as in the proteasome, DNA topoisomerase, matrix metalloproteinase, and ABC drug transporter proteins.(34,35) Several studies have reported its antitumor and chemotherapy-sensitizing activities in various cancer cells,…”
BackgroundKaragiannis, G. S., Poutahidis, T., Erdman, S. E., Kirsch, R., Riddell, R. H., & Diamandis, E. P. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0307 · Cited by 507
Longati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.-R., Rehnmark, S., Verbeke, C., Toftgård, R., Löhr, M., & Heuchel, R. L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-95 · Cited by 394
Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin
Lin, R.-Z., Chou, L.-F., Chien, C.-C. M., & Chang, H.-Y. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0148-2 · Cited by 305 · cited 1×
“The different 3D-forming ability among the tested panel of cells is likely due to the different expression levels of adhesion molecules, such as β1-integrin and E-cadherin, and the interaction of β1-integrin with ECM proteins, which are required during spheroid formation, similarly to what has been demonstrated in hep…”
BackgroundSlack, J. (2007) · Principles of Tissue Engineering · doi:10.1016/b978-012370615-7/50009-3 · Cited by 237
Diversity of cell-mediated adhesions in breast cancer spheroids
Ivascu, A., & Kubbies, M. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.6.1403 · Cited by 229
Jaffee, E. M., Hruban, R. H., Canto, M., & Kern, S. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00093-4 · Cited by 215
Modeling Pancreatic Cancer with Organoids
Baker, L. A., Tiriac, H., Clevers, H., & Tuveson, D. A. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.03.004 · Cited by 210 · cited 1×
“Organoids, on the other hand, are defined as 3D cellular clusters typically derived specifically from primary tissue, embryonic stem cells, or induced pluripotent stem cells.(2,3,12) Organoid cultures traditionally rely on artificial extracellular matrices (ECMs) such as Matrigel to facilitate their self-organization…”
BackgroundSelf-citationIntegrin Signaling in Cancer Cell Survival and Chemoresistance
Aoudjit, F., & Vuori, K. (2012) · Chemotherapy Research and Practice · doi:10.1155/2012/283181 · Cited by 205 · cited 2×
“The significant loss of cytotoxicity by microtubule modulators in ECM-rich 3D cultures observed in this study is consistent with expectations, which further supports an ECM-mediated drug resistance mechanism in 3D cell culture.(33) This phenomenon was also observed in hM1CAF to some degree, but not in hT1 and hT1-CAF.”
ResultMadoux, F., Dreymuller, D., Pettiloud, J.-P., Santos, R., Becker-Pauly, C., Ludwig, A., Fields, G. B., Bannister, T., Spicer, T. P., Cudic, M., et al. (2016) · Scientific Reports · doi:10.1038/s41598-016-0013-4 · Cited by 180
Self-citationA spheroid toxicity assay using magnetic 3D bioprinting and real-time mobile device-based imaging
Tseng, H., Gage, J. A., Shen, T., Haisler, W. L., Neeley, S. K., Shiao, S., Chen, J., Desai, P. K., Liao, A., Hebel, C., et al. (2015) · Scientific Reports · doi:10.1038/srep13987 · Cited by 148 · cited 1×
“In this study, we focus on the development of HTS-amenable 3D pancreatic cancer cell culture in standard flat-bottom well plates by combining a cell-repellant surface with a bioprinting technology that relies on magnetic force.(13,20) We applied a parallel 384well HTS approach to test the National Cancer Institute (NC…”
MethodSelf-citationBoehnke, K., Iversen, P. W., Schumacher, D., Lallena, M. J., Haro, R., Amat, J., Haybaeck, J., Liebs, S., Lange, M., Schäfer, R., et al. (2016) · SLAS Discovery · doi:10.1177/1087057116650965 · Cited by 144 · cited 1×
“Therefore, physiologically relevant 3D cell culture has been recognized as a potential bridge between traditional in vitro two-dimensional (2D) culture and in vivo animal studies.(7,8) It is thus critical to advance the development of scalable and affordable methods of producing 3D spheroids and/or organoids suitable…”
MethodPancreatic Cancer and Tumor Microenvironment
Grippo, P. J., & Munshi, H. G. (2012) · Cited by 131
Lövborg, H., Öberg, F., Rickardson, L., Gullbo, J., Nygren, P., & Larsson, R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21534 · Cited by 128
Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Neeße, A., Gress, T. M., Tuveson, D. A., Michl, P., & Krug, S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38111 · Cited by 98 · cited 1×
“Disulfiram, an aldehyde dehydrogenase inhibitor, has also been shown to inhibit other actvities, such as in the proteasome, DNA topoisomerase, matrix metalloproteinase, and ABC drug transporter proteins.(34,35) Several studies have reported its antitumor and chemotherapy-sensitizing activities in various cancer cells,…”
BackgroundSelf-citationA 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids
Madoux, F., Tanner, A., Vessels, M., Willetts, L., Hou, S., Scampavia, L., & Spicer, T. P. (2017) · SLAS Discovery · doi:10.1177/2472555216686308 · Cited by 72 · cited 4×
“The essential requirement for implementation of 3D tumor models for HTS therapeutic screening is to efficiently and economically produce and/or seed uniform spheroids or organoids in high-density microplates and to achieve acceptable HTS assay performance.(4) In this study, we focus on the development of HTS-amenable…”
BackgroundMethodInfluentialSelf-citationPedró-Rosa, L., C, F. S. B. A., Ranade, R. M., Eberhart, C., Madoux, F., Gillespie, J. R., Koh, C. Y., Brown, S. J., Lohse, J., Verlinde, C. L. M. J., et al. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114548832 · Cited by 40 · cited 1×
“G7573, Promega, Madison, WI) as previously described.(22) Prior to plating, cells were grown to 80% confluence in RPMI 1640 complete growth media.”
MethodSelf-citationLarge-scale pharmacological profiling of 3D tumor models of cancer cells
Griner, L. A. M., Zhang, X., Guha, R., McKnight, C. G., Goldlust, I. S., Lal‐Nag, M., Wilson, K. M., Michael, S., Titus, S., Shinn, P., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.360 · Cited by 37 · cited 2×
“In comparison with another laboratory’s results, similar differential activity of trametinib was reported in PANC-1 2D and 3D culture models.(32) It is also a cytotoxic compound that is more effective against pancreatic cancer cells over its counterpart CAFs in 3D assays (Figs.”
BackgroundResultSmith, E. W., Chase, P. S., Niswender, C. M., Utley, T. J., Sheffler, D. J., Noetzel, M. J., Lamsal, A., Wood, M. R., Conn, P. J., Lindsley, C. W., et al. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115581770 · Cited by 33
Self-citationDynamic changes during the treatment of pancreatic cancer
Wolff, R. A., Wang‐Gillam, A., Alvarez, H., Tiriac, H., Engle, D. D., Hou, S., Groff, A. F., Lucas, A. S., Bernard, V., Allenson, K., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24483 · Cited by 29 · cited 1×
“Additionally, while this study focused on the use of cell-repellent surfaces for 3D technologies, reported outcomes when testing hM1 cells in either Matrigel or n3D formats are available.(29) The same panel of cells cultured in Corning spheroid plates preserved the morphology found using n3D bioprinting technology (Fi…”
Self-citationAssessing Drug Efficacy in a Miniaturized Pancreatic Cancer In Vitro 3D Cell Culture Model
Shelper, T., Lovitt, C. J., & Avery, V. M. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2016.737 · Cited by 19
Powell, K. (2017) · Science · doi:10.1126/science.356.6333.96 · Cited by 9 · cited 1×
“Organoids, on the other hand, are defined as 3D cellular clusters typically derived specifically from primary tissue, embryonic stem cells, or induced pluripotent stem cells.(2,3,12) Organoid cultures traditionally rely on artificial extracellular matrices (ECMs) such as Matrigel to facilitate their self-organization…”
Background
Cited by
Progress in 3D bioprinting technology for tissue/organ regenerative engineering
Matai, I., Kaur, G., Seyedsalehi, A., McClinton, A., & Laurencin, C. T. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119536 · Cited by 1,156
Optimizing the outcomes of pancreatic cancer surgery
Strobel, O., Neoptolemos, J., Jäger, D., & Büchler, M. W. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0112-1 · Cited by 943
Chemotherapy for pancreatic cancer
Springfeld, C., Jäger, D., Büchler, M. W., Strobel, O., Hackert, T., Palmer, D. H., & Neoptolemos, J. P. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.02.025 · Cited by 281
Tumor organoid models in precision medicine and investigating cancer-stromal interactions
Xu, R., Zhou, X., Wang, S., & Trinkle, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107668 · Cited by 134
Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening
Du, Y., Li, X., Niu, Q., Mo, X., Qui, M., Ma, T., Kuo, C. J., & Fu, H. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa036 · Cited by 125
Metadata
- Authors
- Hou, S., Tiriac, H., Sridharan, B. P., Scampavia, L., Madoux, F., Seldin, J., Souza, G. R., Watson, D., Tuveson, D., & Spicer, T. P.
- Venue
- SLAS Discovery
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 23
- Issue
- 6
- Pages
- 574-584
- ISSN
- 2472-5552 (ISSN-L)
- OpenAlex
- W2801652358
- Cited by
- 169
- References
- 35
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.